US Stocks
/
AIM ImmunoTech Inc. Share Price
AIM ImmunoTech Inc. Share Price

AIM ImmunoTech Inc. Share Price

AMEX: AIM | Micro Cap
$0.19
+$0.00 (0.87%) Last updated on 08 Oct, 2026 | 01:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AIM ImmunoTech Inc. Stock Performance

Open
$0.19
Prev. Close
$0.18
Circuit Range
N/A
Day Range
$0.19 - $0.19
Year Range
$0.17 - $2.79
Volume
610
Average Traded
$0.19

AIM ImmunoTech Inc. Share Price Today

As of 8 October 2026, AIM ImmunoTech Inc.'s share price is $0.19. The stock opened at $0.19, compared to its previous close of $0.18. During today's trading session, AIM ImmunoTech Inc.'s share price traded between $0.19 and $0.19, with an average price of $0.19. Over the past 52 weeks, the stock has recorded a high of $2.79 and a low of $0.17. In terms of performance, AIM ImmunoTech Inc.'s share price has declined by 64.57% over the last six months and is down 91.22% on a year-on-year basis.

AIM ImmunoTech Inc. Share Price Chart

$0.19$0.19
L
Show Current Price
H

AIM ImmunoTech Inc. Stock Fundamentals & Key Indicators

Market Cap
$299929.73
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.44
Revenue (TTM)
$90.00M
Return On Equity (TTM)
-225.59%
Profit Margin
-15511.11%
Debt to Equity
0.47
Quarterly Earnings Growth YoY
-113.11%

AIM ImmunoTech Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.03$0.02$0.02$0.03
Net Profit-$3.28-$4.18-$3.02-$6.99
Net Profit Margin-10933.33%-20900.00%-15100.00%-23300.00%
Income ChangeN/A-27.44%27.75%-131.46%

AIM ImmunoTech Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.14$0.20$0.17$0.09
Net Profit-$19.45-$28.96-$17.32-$13.96
Net Profit Margin-13892.86%-14480.00%-10188.24%-15511.11%
Income ChangeN/A-48.89%40.19%19.40%

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

AIM ImmunoTech Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.17
$0.18
+5.11%
Sep 2026
$0.24
$0.18
-30.71%
Aug 2026
$0.26
$0.25
-1.17%
Jul 2026
$0.28
$0.26
-7.55%
Jun 2026
$0.56
$0.28
-32.52%
May 2026
$0.53
$0.41
-21.22%
Apr 2026
$0.60
$0.52
-6.10%
Mar 2026
$0.93
$0.56
-38.38%
Feb 2026
$1.11
$0.90
-24.67%
Jan 2026
$1.20
$1.20
+8.11%
Dec 2025
$1.59
$1.11
-26.73%
Nov 2025
$2.02
$1.51
-28.20%

AIM Share Price FAQs

What is AIM ImmunoTech Inc. share price today?

chevron-up
AIM ImmunoTech Inc. share price today is $0.19 as on October 8, 2026 at 1:12 am IST.

What is the 52 week high and 52 week low of AIM ImmunoTech Inc. stock?

chevron-up
The 52 week high of AIM ImmunoTech Inc. stock is $2.79, while the 52 week low is $0.17 as of 8 Oct '26.

What is AIM's market capitalisation today?

chevron-up
AIM market capitalisation is $299929.73 as of October 8, 2026, at 4:07 pm IST.

What is AIM's net income for the last quarter?

chevron-up
AIM's net income for the last quarter is -6.99B USD.

What is the 5 year returns of AIM?

chevron-up
The 5 year returns of AIM is -89.65% as on 8 Oct '26.

What is the high & low stock price of AIM today?

chevron-up
AIM stock price hit a high of $0.19 and low of $0.19 as of 8 Oct '26.

Can I buy AIM shares in India?

chevron-up
Yes. You can buy AIM in India by opening an international trading account.